Cargando…

Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine for the Prevention of Genital Warts in Males: Profile Report

Detalles Bibliográficos
Autores principales:	Garnock-Jones, Karly P., Giuliano, Anna R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2012
Materias:	Adis Profile Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585902/ https://www.ncbi.nlm.nih.gov/pubmed/23017129 http://dx.doi.org/10.2165/11207000-000000000-00000

Ejemplares similares

The quadrivalent HPV vaccine is protective against genital warts: a meta-analysis
por: Lukács, Anita, et al.
Publicado: (2020)

Early Direct and Indirect Impact of Quadrivalent HPV (4HPV) Vaccine on Genital Warts: a Systematic Review
por: Mariani, Luciano, et al.
Publicado: (2015)

Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study
por: Dominiak-Felden, Geraldine, et al.
Publicado: (2015)

Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax(®) Tetra/Flucelvax Quadrivalent(®)): A Review in the Prevention of Influenza
por: Lamb, Yvette N.
Publicado: (2019)

Correction: Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study
por: Dominiak-Felden, Geraldine, et al.
Publicado: (2016)

Declining Genital Warts in Young Women in England Associated With HPV 16/18 Vaccination: An Ecological Study
por: Howell-Jones, Rebecca, et al.
Publicado: (2013)

Can quadrivalent human papillomavirus prophylactic vaccine be an effective alternative for the therapeutic management of genital warts? an exploratory study
por: Choi, Hoon
Publicado: (2019)

Methylphenidate Transdermal System in Attention-Deficit Hyperactivity Disorder in Adolescentsy: Profile Report
por: Keating, Gillian M.
Publicado: (2012)

Immune Globulin Subcutaneous (Human) 20%: In Primary Immunodeficiency Disorders
por: McCormack, Paul L.
Publicado: (2012)

FebriDx(®): A Rapid Diagnostic Test for Differentiating Bacterial and Viral Aetiologies in Acute Respiratory Infections
por: Shirley, Matt
Publicado: (2019)

Prevalence and Determinants of High-Risk Human Papillomavirus Infection in Male Genital Warts
por: Park, Sung Jin, et al.
Publicado: (2014)

Synchytrium endobioticum, the potato wart disease pathogen
por: van de Vossenberg, Bart. T. L. H., et al.
Publicado: (2022)

Prevention of cervical, vaginal, and vulval cancers: role of the quadrivalent human papillomavirus (6, 11, 16, 18) recombinant vaccine
por: Diaz, Maria Lina
Publicado: (2010)

Incidence of anogenital warts after the introduction of the quadrivalent HPV vaccine program in Manitoba, Canada
por: Righolt, Christiaan H., et al.
Publicado: (2022)

Characteristics of human papillomaviruses infection in men with genital warts in Shanghai
por: Chen, Xiaogang, et al.
Publicado: (2016)

Quadrivalent Human Papillomavirus (HPV) Vaccine Induces HPV-Specific Antibodies in the Oral Cavity: Results From the Mid-Adult Male Vaccine Trial
por: Pinto, Ligia A., et al.
Publicado: (2016)

High genital prevalence of cutaneous human papillomavirus DNA on male genital skin: the HPV Infection in Men Study
por: Sichero, Laura, et al.
Publicado: (2014)

Multiple Human Papillomavirus Infection Is Associated with High-Risk Infection in Male Genital Warts in Ulsan, Korea
por: Kwon, Taekmin, et al.
Publicado: (2016)

Incident HPV 51 Infection After Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine Gardasil/Silgard(®)
por: Halfon, Philippe, et al.
Publicado: (2010)

Cohort Profile: African Collaborative Center for Microbiome and Genomics Research’s (ACCME's) Human Papillomavirus (HPV) and Cervical Cancer Study
por: Adebamowo, Sally N, et al.
Publicado: (2017)

Epidemiology of genital warts in the British population: implications for HPV vaccination programmes
por: Sonnenberg, Pam, et al.
Publicado: (2019)

A novel vaccine for cervical cancer: quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil(®))
por: Govan, Vandana A
Publicado: (2008)

Fidaxomicin: Difimicin; Lipiarmycin; OPT 80; OPT-80; PAR 101; PAR-101
Publicado: (2012)

Brentuximab Vedotin
Publicado: (2012)

Tofacitinib
Publicado: (2012)

Belimumab: Anti-BLyS Monoclonal Antibody; Benlysta™; BmAb; LymphoStat-B
Publicado: (2012)

Dalcetrapib: JTT 705; JTT-705; R 1658; R1658; RG1658; RO 4607381; RO4607381
Publicado: (2012)

Boceprevir
Publicado: (2012)

Telaprevir
Publicado: (2012)

Ridaforolimus
Publicado: (2012)

Tremelimumab
Publicado: (2012)

Linifanib
Publicado: (2012)

Naltrexone/Bupropion: Contrave®; Naltrexone SR/Bupropion SR
Publicado: (2012)

Dapagliflozin: BMS 512148; BMS-512148
Publicado: (2012)

Ipilimumab
Publicado: (2012)

Abiraterone Acetate
Publicado: (2012)

Mismatched Double-Stranded RNA: PolyI:PolyC12U
Publicado: (2012)

Treatment of genital wart
por: Narsinghani, Pinki A., et al.
Publicado: (2016)

Giant genital warts
por: Georgopoulos, Ioannis, et al.
Publicado: (2018)

Cryotherapy of Genital Warts
por: Jahic, Mahira
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_giklc21oa1cmhc26os57v80kfd